Testing SBS-147 in healthy adults for safety
Part of Pain clinical trials.
This study tests a new drug, SBS-147, in healthy adults to see if it's safe and how the body processes it. It may help find the right dose for future studies in people with certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 55 years old.
- Your body mass index (BMI) is between 18.0 and 32.0.
- You weigh at least 50 kg (about 110 pounds).
- You do not smoke and have not smoked for at least 90 days.
- You are willing to follow study rules and attend all visits.
- You have no major health problems like heart, lung, or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study tests a new investigational drug called HRS-6257 in healthy volunteers. It looks at how the drug works in the body and checks for side effects after one or several doses.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This study tests a new drug called SSS67 given as a single injection into a vein. It aims to see how safe it is in healthy adults and how the body processes it.
This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.
This trial tests a new medication called 627 in healthy adults to see how safe it is and how the body processes it. It's a first-in-human study, so the main goal is to make sure the drug is well-tolerated.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.